Wegovy and similar weight-loss medications are becoming widely prescribed for teenagers with obesity, but little is known ...

First the drugs tackled diabetes. Then, with just an injection a week, they took on obesity. Now they are being found to ...

The findings spell an uncertain future for hospitals and clinics that derive a significant portion of their revenues from ...

A University of Alberta pharmacology researcher has discovered that a new experimental anti-obesity drug improves diastolic ...

Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims ...

Expanding access to cutting-edge diabetes and weight-loss drugs like Ozempic and Zepbound could prevent more than 42,000 ...

While all state Medicaid programs cover GLP-1 agonists for type 2 diabetes, it’s much less common for them to cover the drugs ...

Despite the benefits of such medicines, like Wegovy, Saxenda and Zepbound, many people who could most benefit from them can’t ...

“We know that generally, with and without obesity, mental health and suicidality is ... who has done similar work analyzing ...

New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that insurers are ...

Truist analyst Srikripa Devarakonda backs away from bullish call as competition mutes potential for biotech’s drug pipeline.

The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in ...